Traditional Chinese medicine composition for promoting ablation of atherosclerotic plaque and pulmonary nodule as well as preparation method and application of traditional Chinese medicine composition

Through the combined use of specific proportions of traditional Chinese medicine compositions and complex bacterial species, the problem of atherosclerosis and pulmonary nodules is solved, effective ablation of atherosclerosis plaques and pulmonary nodules is achieved, and the treatment is significantly improved Effect.

CN118903339AInactive Publication Date: 2024-11-08BEIJING YONGKANGNIAN HEALTH TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411259590.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-09
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The prior art is difficult to effectively treat atherosclerosis and pulmonary nodules, especially traditional Chinese medicine compositions that ablate atherosclerosis plaques and pulmonary nodules, and are relatively lacking in clinical applications.

Method used

Provided is a traditional Chinese medicine composition, including jujube seeds, atractylodes, longan meat, safflower, almonds, Cordyceps sinensis, Cistanche, Astragalus, Polygonatum, ginseng, peach kernel, wolfberry, orange peel, platycodon, angelica, Ophiopogon japonicus, malt and large Date, prepared by specific extraction and fermentation methods, combines complex bacterial species such as Angelica yeast and Bifidobacterium lactis to enhance the activity of the drug.

Benefits of technology

This traditional Chinese medicine composition significantly promotes the ablation of atherosclerotic plaques and lung nodules through the effects of replenishing qi, replenishing blood, promoting blood circulation, eliminating blood stasis, and unblocking meridians, thereby improving the circulating and metabolic function of the body, and has significant therapeutic effects.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention provides a traditional Chinese medicine composition for promoting ablation of atherosclerotic plaques and pulmonary nodules as well as a preparation method and application of the traditional Chinese medicine composition, and belongs to the technical field of disease treatment medicines. The traditional Chinese medicine composition provided by the invention is prepared from the following raw materials: semen ziziphi spinosae, rhizoma atractylodis macrocephalae, arillus longan, flos carthami, apricot kernels, cordyceps militaris, herba cistanche, radix astragali, rhizoma polygonati, ginseng, peach kernels, fructus lycii, orange peel, radix platycodonis, radix angelicae sinensis, radix ophiopogonis, fructus hordei germinatus and fructus ziziphi jujubae. The traditional Chinese medicine composition provided by the invention has the main effects of tonifying qi, enriching blood and tonifying liver and kidney, improves the circulation metabolism function of the body, exerts the effects of strengthening bones and generating marrow, and finally can promote the generation of immune phagocytes and cholesterol esterase by cooperating with the effects of promoting blood circulation, removing blood stasis and dredging collaterals; ablation of atherosclerotic plaques and pulmonary nodules is promoted from multiple ways, multiple links and multiple targets.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of disease treatment drugs, and in particular relates to a traditional Chinese medicine composition for promoting ablation of atherosclerotic plaques and pulmonary nodules, and a preparation method and application thereof. Background Art

[0002] Atherosclerosis refers to the deposition of blood components such as lipids, smooth muscle cell proliferation and increased collagen fibers in the arterial intima, forming atherosclerotic lipid-containing necrotic lesions and vascular wall sclerosis. The basic pathological change of atherosclerosis is the formation of plaques on the surface of the arterial intima, including lipid streaks, fibrous plaques and atherosclerotic plaques. Its etiology and pathogenesis are complex and have not yet been fully elucidated. Hypertension, hyperglycemia, hyperlipidemia, obesity, insulin resistance, smoking, age, family history, etc. are all factors that lead to atherosclerosis. At present, clinical measures to combat atherosclerotic diseases are still mainly limited to invasive percutaneous angioplasty and poor comprehensive medical treatment. Therefore, finding a safe, effective, and clinically operable method and drug for reversing atherosclerosis has always been a difficult problem that needs to be solved in this field.

[0003] In the field of traditional Chinese medicine, scholars hold different views on the etiology and pathogenesis of atherosclerosis. For example, some scholars believe that the etiology and pathogenesis of atherosclerosis are mainly liver, spleen, and kidney deficiency, endogenous blood fatigue and phlegm turbidity, endogenous toxins, dampness and heat, and the interaction of blood fatigue, phlegm alone, and qi deficiency is the key pathogenesis of atherosclerosis. Some scholars believe that atherosclerosis, as the common pathological basis of major heart and brain diseases, is rooted in qi (yang) deficiency, and its symptoms are phlegm turbidity and blood stasis. Qi deficiency is the main symptom at the beginning of the disease, followed by phlegm and blood stasis, and finally phlegm and blood stasis are intertwined and stagnant in the meridians. Some scholars believe that "phlegm and blood stasis" is the most important pathological factor of atherosclerosis. Spleen deficiency and improper diet are the internal and external causes of endogenous phlegm turbidity. Phlegm turbidity can condense in the heart veins, causing the heart veins to stagnate and fatigue, and then phlegm and blood stasis are intertwined, deposited in the blood vessels, and develop atherosclerosis. Although there have been reports in the art on the use of traditional Chinese medicine prescriptions to treat atherosclerotic diseases, there are very few traditional Chinese medicine compositions for ablating atherosclerotic plaques, and the traditional Chinese medicine compositions that can actually be used for clinical treatment are even more limited.

[0004] At present, the field defines lung nodules as focal, round, solid or subsolid shadows with a diameter of ≤30 mm, which may be isolated or multiple, without atelectasis, hilar lymphadenopathy, or pleural effusion. CT observations have shown that lung nodules will increase in size and number over time. With the extension of the duration of lung nodules and the stimulation of external factors, multiple lung nodules may undergo "inflammatory-cancer transformation". Therefore, ablation of lung nodules is very necessary for the health of the body. Summary of the invention

[0005] In view of this, one of the objects of the present invention is to provide a traditional Chinese medicine composition that promotes the ablation of atherosclerotic plaques and pulmonary nodules, which can effectively ablate atherosclerotic plaques and pulmonary nodules and has significant efficacy in the treatment of atherosclerotic diseases and pulmonary nodules.

[0006] The second object of the present invention is to provide a method for preparing the above-mentioned Chinese medicine composition.

[0007] The third object of the present invention is to provide the use of the above-mentioned Chinese medicine composition or the above-mentioned preparation method in the preparation of products for treating atherosclerosis.

[0008] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0009] The invention provides a traditional Chinese medicine composition for treating atherosclerotic plaques. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 10-20 parts of spiny jujube seeds, 7-14 parts of atractylodes macrocephala, 15-20 parts of longan pulp, 6-12 parts of safflower, 9-18 parts of apricot kernel, 5-10 parts of cordyceps militaris, 3-6 parts of cistanche deserticola, 9-16 parts of astragalus, 10-15 parts of polygonatum, 6-10 parts of ginseng, 2-8 parts of peach kernel, 4-10 parts of wolfberry, 12-16 parts of tangerine peel, 13-18 parts of platycodon, 20-30 parts of angelica, 10-15 parts of ophiopogon japonicus, 16-22 parts of malt and 8-16 parts of jujube.

[0010] The present invention also provides a method for preparing the above-mentioned traditional Chinese medicine composition, comprising the following steps: mixing spiny jujube seeds, white atractylodes, longan pulp and safflower to obtain a mixture 1, mixing the mixture 1 with an ethanol solution with a volume fraction of 70%-90%, refluxing extraction, filtering to obtain a filtrate 1 and a filter residue 1, and removing the ethanol solution in the filtrate 1 to obtain an alcohol extract;

[0011] Apricot kernel, Cistanche deserticola, Astragalus, Polygonatum sibiricum, Ginseng, and Platycodon grandiflorum are mixed to obtain a mixture 2, and the mixture 2 is mixed with water, soaked, boiled, and filtered to obtain a filtrate 2 and a filter residue 2;

[0012] Steaming peach kernels, orange peels and angelica sinensis to obtain a steamed product, mixing the steamed product with 40-degree liquor and frying for 10-20 minutes to obtain a stir-fried product;

[0013] Cordyceps militaris, wolfberry, ophiopogon japonicus, malt, jujube, filter residue 1, filter residue 2 and stir-fried product are mixed to obtain mixture 3; mixture 3 is mixed with composite bacteria, and sealed and fermented for 4-7 days at 25-30°C to obtain fermentation product; the fermentation product, alcohol extract and filtrate 2 are mixed to obtain the Chinese medicine composition; the composite bacteria are composed of Angel yeast and Bifidobacterium lactis, and the number of viable bacteria of the composite bacteria is 2×10 8 CFU / g and above.

[0014] Preferably, the mass volume ratio of the mixture 1 to the ethanol solution with a volume fraction of 70%-90% is 1g:3-5mL.

[0015] Preferably, the mass volume ratio of the mixture 2 to water is 1 g:4-6 mL.

[0016] Preferably, the soaking time is 30-50 min.

[0017] Preferably, the decocting time is 0.5-1.5h.

[0018] Preferably, the mass volume ratio of the steamed product to 40-proof liquor is 1 g: 0.2-0.5 mL.

[0019] Preferably, the amount of the composite bacteria is calculated based on the weight of the mixture 3, with 0.2-0.5 g of the composite bacteria added per 100 g of the mixture 3.

[0020] Preferably, the weight ratio of Angel Yeast to Bifidobacterium lactis in the composite bacteria is 1:2-3.

[0021] The present invention also provides the use of the above-mentioned traditional Chinese medicine composition or the above-mentioned preparation method in the preparation of atherosclerotic plaque ablation and / or pulmonary nodule ablation products.

[0022] Beneficial effects of the present invention:

[0023] The Chinese medicine composition provided by the present invention mainly replenishes qi, blood, and liver and kidney, improves the body's own circulation and metabolism function, and plays a role in strengthening bones and producing marrow, and then cooperates with blood circulation, removing blood stasis and unblocking collaterals, and can eventually promote the generation of immune phagocytes and cholesterol esterase, and promote the ablation of atherosclerotic plaques and pulmonary nodules from multiple pathways, multiple links and multiple targets. The Chinese medicine composition provided by the present invention adopts the principle of treatment by replenishing and ablating, adopts a unique preparation method, and achieves the effect of effectively ablating atherosclerotic plaques and pulmonary nodules on the basis of replenishing the spleen, stomach, liver, kidney and lung, and softening blood vessels, preventing cholesterol lipids from being deposited in the blood vessel wall, and has a significant therapeutic effect for the prevention and treatment of atherosclerotic diseases and the ablation of pulmonary nodules. DETAILED DESCRIPTION

[0024] The invention provides a traditional Chinese medicine composition for treating atherosclerotic plaques. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 10-20 parts of spiny jujube seeds, 7-14 parts of atractylodes macrocephala, 15-20 parts of longan pulp, 6-12 parts of safflower, 9-18 parts of apricot kernel, 5-10 parts of cordyceps militaris, 3-6 parts of cistanche deserticola, 9-16 parts of astragalus, 10-15 parts of polygonatum, 6-10 parts of ginseng, 2-8 parts of peach kernel, 4-10 parts of wolfberry, 12-16 parts of tangerine peel, 13-18 parts of platycodon, 20-30 parts of angelica, 10-15 parts of ophiopogon japonicus, 16-22 parts of malt and 8-16 parts of jujube.

[0025] In the present invention, angelica nourishes blood and invigorates blood circulation, astragalus nourishes qi and raises yang, ginseng nourishes spleen and lungs, polygonatum nourishes qi and nourishes yin, strengthens spleen and kidneys, and longan meat nourishes blood deficiency. The above five are monarch drugs, which play the role of nourishing qi and blood, nourishing liver and kidneys, regulating qi and invigorating lungs, nourishing kidneys and then strengthening bones and producing marrow, and promoting the generation of immune phagocytes. Ziziphus jujuba seeds calm the mind, and are combined with Atractylodes macrocephala to dry dampness, invigorate spleen and resolve phlegm, and eliminate the source of phlegm; safflower promotes blood circulation and dredges menstruation, dissipates blood stasis and relieves pain; almonds relieve cough and asthma; tangerine peel regulates qi; platycodon clears heat and resolves phlegm; the above six herbs are minister drugs, which promote blood circulation and remove blood stasis, provide nutrients for immune phagocytes to function, and make immune phagocytes have higher vitality. The medicine is supplemented with Cordyceps militaris, Cistanche deserticola, peach kernel, wolfberry, Ophiopogon japonicus and malt. Cordyceps militaris can activate the activity of the body's immune phagocytes, significantly improve the phagocytic function of immune phagocytes, promote immune phagocytes to phagocytize abnormally deposited plaque components in arterial blood vessels, promote arterial wall softening, significantly increase cell energy charge, lower blood pressure, dilate cardiovascular and cerebrovascular vessels, regulate blood viscosity, and inhibit lipid deposition on blood vessel walls; Cistanche deserticola can nourish kidney yang, benefit essence and blood, moisten the intestines and relieve constipation, and can significantly improve the phagocytic and secretory functions of macrophages, thereby activating macrophages, promoting macrophages to phagocytize arteriosclerotic plaques and lung nodules, and promoting arterial wall structure remodeling; peach kernel can promote blood circulation and eliminate phlegm, moisten the intestines and relieve constipation; wolfberry can nourish the liver and kidneys and enhance immune function; Ophiopogon japonicus can nourish yin and produce body fluid, moisten the lungs and clear the heart, and has the effects of resisting hypoxia, lowering blood sugar and promoting immunity; malt can promote qi and digestion, strengthen the spleen and stimulate the appetite, and has the effects of lowering blood lipids and protecting the liver; the above six herbs are adjuvants. Jujube is mild in nature and sweet in taste, nourishes the middle and replenishes qi, nourishes the stomach and invigorates the spleen, nourishes blood and strengthens the spirit, moistens the heart and lungs, regulates the Yingwei, produces body fluids, makes the complexion happy, clears the nine orifices, helps the twelve meridians, and harmonizes hundreds of medicines, which is a drug. The present invention is mainly based on invigorating qi, invigorating blood, and invigorating the liver and kidneys, improves the circulation and metabolism function of the body itself, and plays the role of strengthening bones and producing marrow, and then cooperates with activating blood circulation, removing blood stasis and unblocking collaterals, and finally can promote the generation of immune phagocytes, and treats atherosclerotic diseases from multiple pathways, multiple links and multiple targets. Damp phlegm and blood stasis are the basis of "inflammation-cancer transformation", and the loss of vital energy is the key to "inflammation-cancer transformation", and qi deficiency and yang deficiency are the root of vital energy loss, and emotional depression and damp phlegm and blood stasis are the driving forces of "inflammation-cancer transformation". The present invention mainly takes supplementation as its main function, improves the body's own metabolic function, promotes the production of the body's own cholesterol esterase and immune macrophages, and then uses auxiliary drugs and adjuvant drugs to improve the activity of immune macrophages and cholesterol esterase, ultimately achieving the significant beneficial effect of promoting the ablation of atherosclerotic plaques and lung nodules from multiple pathways, multiple links and multiple targets.

[0026] In the present invention, the weight portion of the Chinese date seed is preferably 12-18 parts, and more preferably 14-16 parts; the weight portion of the white atractylodes is preferably 8-13 parts, and more preferably 10-12 parts; the weight portion of the longan pulp is preferably 16-19 parts, and more preferably 17-18 parts; the weight portion of the safflower is preferably 7-11 parts, and more preferably 8-10 parts; the weight portion of the almond is preferably 10-16 parts, and more preferably 12-14 parts; the weight portion of the cordyceps militaris is preferably 6-9 parts, and more preferably 7-8 parts; the weight portion of the Cistanche deserticola is preferably 4-5 parts; the weight portion of the astragalus is preferably 11-15 parts, and more preferably 12-14 parts; the weight portion of the polygonatum is preferably 11-14 parts, and more preferably 12-1 3 parts; the weight of the ginseng is preferably 7-9 parts, more preferably 8 parts; the weight of the peach kernel is preferably 3-7 parts, more preferably 4-6 parts; the weight of the wolfberry is preferably 5-9 parts, more preferably 6-8 parts; the weight of the tangerine peel is preferably 13-15 parts, more preferably 14 parts; the weight of the platycodon is preferably 14-17 parts, more preferably 15-16 parts; the weight of the angelica is preferably 22-28 parts, more preferably 24-26 parts; the weight of the ophiopogon is preferably 11-14 parts, more preferably 12-13 parts; the weight of the malt is preferably 17-21 parts, more preferably 18-20 parts; the weight of the jujube is preferably 10-14 parts, more preferably 11-13 parts.

[0027] The present invention also provides a method for preparing the above-mentioned traditional Chinese medicine composition, comprising the following steps: mixing spiny jujube seeds, white atractylodes, longan pulp and safflower to obtain a mixture 1, mixing the mixture 1 with an ethanol solution with a volume fraction of 70%-90%, refluxing extraction, filtering to obtain a filtrate 1 and a filter residue 1, and removing the ethanol solution in the filtrate 1 to obtain an alcohol extract;

[0028] Apricot kernel, Cistanche deserticola, Astragalus, Polygonatum sibiricum, Ginseng, and Platycodon grandiflorum are mixed to obtain a mixture 2, and the mixture 2 is mixed with water, soaked, boiled, and filtered to obtain a filtrate 2 and a filter residue 2;

[0029] Steaming peach kernels, orange peels and angelica sinensis to obtain a steamed product, mixing the steamed product with 40-degree liquor and frying for 10-20 minutes to obtain a stir-fried product;

[0030] Cordyceps militaris, wolfberry, ophiopogon japonicus, malt, jujube, filter residue 1, filter residue 2 and stir-fried product are mixed to obtain mixture 3; mixture 3 is mixed with composite bacteria, and sealed and fermented for 4-7 days at 25-30°C to obtain fermentation product; the fermentation product, alcohol extract and filtrate 2 are mixed to obtain the Chinese medicine composition; the composite bacteria are composed of Angel yeast and Bifidobacterium lactis, and the number of viable bacteria of the composite bacteria is 2×10 8 CFU / g and above.

[0031] In the preparation method of the present invention, it is preferred that the spiny jujube seeds, white atractylodes, longan pulp and safflower are crushed and then subjected to ethanol reflux extraction. The present invention has no special requirements for the specific method of crushing and the crushed particle size. In the present invention, the volume fraction of the ethanol solution is preferably 75%-85%, and more preferably 79%-82%; the mass volume ratio of the mixture 1 to the ethanol solution with a volume fraction of 70%-90% is preferably 1g:3-5mL, and more preferably 1g:4mL. In the present invention, the number of reflux extractions is preferably more than 2 times. The present invention has no special restrictions on the specific temperature of the reflux extraction, and it can be kept in a boiling state. In the present invention, the time of the reflux extraction is preferably 30min-70min, and more preferably 40min-60min. The volume of the ethanol solution added for each reflux extraction, the reflux extraction temperature, the time, etc. are the same as the first reflux extraction. The present invention has no special restrictions on the specific method of removing the ethanol solution in the filtrate 1, and the conventional method of removing the ethanol solution in the art can be used, such as the rotary evaporation method.

[0032] In the present invention, it is preferred that almond, Cistanche deserticola, Astragalus, Polygonatum, ginseng and Platycodon grandiflorum be crushed and then mixed with water for soaking. The present invention has no special requirements for the specific method of crushing and the crushed particle size. In the present invention, the mass volume ratio of the mixture 2 to water is preferably 1g:4-6mL, and more preferably 1g:5mL. The soaking time is preferably 30-50min, and more preferably 35-45min. After the soaking is completed, decocting is performed, and the decoction is preferably decocted over low heat, and the decoction time is preferably 0.5-1.5h, and more preferably 0.8-1.2h.

[0033] In the present invention, the steaming is preferably steaming over high heat, and the steaming time is preferably 20-40 minutes. After the steaming is completed, the product is fried, and the mass volume ratio of the steamed product to the 40-proof liquor is preferably 1 g: 0.2-0.5 mL, more preferably 1 g: 0.3-0.4 mL. The present invention has no special restrictions on the specific liquor brand and source of the 40-proof liquor, and the frying time is preferably 12-18 minutes, more preferably 14-16 minutes, and the frying is preferably frying over high heat.

[0034] In the present invention, Cordyceps militaris, wolfberry, ophiopogon, malt, jujube, filter residue 1, filter residue 2 and stir-fried products are preferably crushed and sieved first, and then mixed and fermented with composite strains. The mesh number of the sieved is preferably 100 mesh. The amount of the composite strain is based on the weight of the mixture 3, preferably adding 0.2-0.5g of composite strain per 100g mixture 3, more preferably adding 0.3-0.4g of composite strain per 100g mixture 3, and the weight ratio of Angel Yeast and Bifidobacterium lactis in the composite strain is preferably 1: 2-3. In the present invention, the temperature of the sealed fermentation is preferably 27-29 ° C, and the time of the sealed fermentation is preferably 5-6 days. In the present invention, after obtaining the fermented product, it is preferably crushed through a 100 mesh sieve, the sieved material is collected, and then mixed with the alcohol extract and the filtrate 2 to obtain the Chinese medicine composition.

[0035] The present invention also provides the use of the above-mentioned Chinese medicine composition or the above-mentioned preparation method in preparing a product for treating atherosclerosis. In the present invention, the product preferably includes a medicine.

[0036] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0037] In the following embodiments, unless otherwise specified, all of them are conventional methods.

[0038] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0039] Example 1

[0040] A traditional Chinese medicine composition for treating atherosclerotic plaques is prepared from the following raw materials: 15g of spiny jujube seeds, 10g of atractylodes macrocephala, 18g of longan pulp, 8g of safflower, 12g of apricot kernel, 8g of cordyceps militaris, 5g of cistanche deserticola, 12g of astragalus, 12g of polygonatum, 8g of ginseng, 5g of peach kernel, 6g of wolfberry, 14g of tangerine peel, 15g of platycodon, 25g of angelica, 12g of ophiopogon japonicus, 19g of malt, and 12g of jujube.

[0041] The preparation method is:

[0042] Crush Semen Ziziphi Spinosae, Atractylodes Macrocephalae, Longan Meat and Safflower through a 10-mesh sieve, collect the sieved materials, and mix them to obtain a mixture 1; add 4 mL of an 80% by volume ethanol solution per 1 g of the mixture 1, mix the mixture 1 with the 80% by volume ethanol solution, reflux extract for 50 min, filter, and obtain a filtrate 1 and a filter residue 1; remove the ethanol solution in the filtrate 1 by rotary evaporation to obtain an alcohol extract;

[0043] Apricot kernel, Cistanche deserticola, Astragalus, Polygonatum sibiricum, Ginseng, and Platycodon grandiflorum were crushed and passed through a 10-mesh sieve, the sieved materials were collected and mixed to obtain a mixture 2, 5 mL of water was added per 1 g of the mixture 2, the mixture 2 was mixed with water and soaked for 40 min, and after the soaking, the mixture was decocted on low heat for 1 h, and filtered to obtain a filtrate 2 and a residue 2;

[0044] Peach kernel, orange peel and angelica are mixed and steamed over high heat for 30 minutes to obtain a steamed product, and 0.3 mL of 40-degree liquor Niulanshan is used per 1 g of the steamed product, and the steamed product is mixed with 40-degree liquor Niulanshan and stir-fried over high heat for 15 minutes to obtain a stir-fried product;

[0045] Cordyceps militaris, wolfberry, ophiopogon japonicus, malt, jujube, filter residue 1, filter residue 2 and stir-fried material were mixed, crushed through a 100-mesh sieve, and the sieved material was collected to obtain a mixture 3; 0.4 g of the composite bacteria was added per 100 g of the mixture 3, and the mixture 3 was mixed with the composite bacteria (the composite bacteria consisted of Angel Yeast and Bifidobacterium lactis (the Bifidobacterium lactis was purchased from Hubei Haijia Biotechnology Co., Ltd.), the weight ratio of Angel Yeast to Bifidobacterium lactis was 1:2, and the viable count of the composite bacteria was 2×10 8 CFU / g or more), and sealed and fermented at 29°C for 5 days to obtain a fermentation product; the fermentation product was crushed and passed through a 100-mesh sieve, the sieved material was collected, and mixed with the alcohol extract and the filtrate 2 to obtain the traditional Chinese medicine composition.

[0046] Example 2

[0047] A traditional Chinese medicine composition for treating atherosclerotic plaques is prepared from the following raw materials: 10g of spiny jujube seeds, 7g of atractylodes macrocephala, 15g of longan pulp, 6g of safflower, 9g of apricot kernel, 5g of cordyceps militaris, 3g of cistanche deserticola, 9g of astragalus, 10g of polygonatum, 6g of ginseng, 2g of peach kernel, 4g of wolfberry, 12g of tangerine peel, 13g of platycodon, 20g of angelica, 10g of ophiopogon japonicus, 16g of malt, and 8g of jujube.

[0048] The preparation method is:

[0049] Crush spiny jujube seeds, white atractylodes, longan pulp and safflower through a 10-mesh sieve, collect the sieved materials, and mix them to obtain a mixture 1; add 3 mL of 90% ethanol solution by volume per 1 g of the mixture 1, mix the mixture 1 with the 90% ethanol solution by volume, reflux extract for 30 minutes, filter, and obtain a filtrate 1 and a residue 1; remove the ethanol solution in the filtrate 1 by rotary evaporation to obtain an alcohol extract;

[0050] Apricot kernel, Cistanche deserticola, Astragalus, Polygonatum sibiricum, Ginseng, and Platycodon grandiflorum were crushed and passed through a 10-mesh sieve, the sieved materials were collected and mixed to obtain a mixture 2, 4 mL of water was added per 1 g of the mixture 2, the mixture 2 was mixed with water and soaked for 30 min, and after the soaking, the mixture was decocted on low heat for 0.5 h, and filtered to obtain a filtrate 2 and a residue 2;

[0051] Peach kernel, orange peel and angelica are mixed and steamed for 20 minutes over high heat to obtain a steamed product. 0.2 mL of 40-degree liquor Jiang Xiaobai is used per 1 g of the steamed product. The steamed product is mixed with 40-degree liquor Jiang Xiaobai and stir-fried for 12 minutes over high heat to obtain a stir-fried product.

[0052] Cordyceps militaris, wolfberry, ophiopogon japonicus, malt, jujube, filter residue 1, filter residue 2 and stir-fried material were mixed, crushed through a 100-mesh sieve, and the sieved material was collected to obtain a mixture 3. 0.2 g of the composite bacteria was added per 100 g of the mixture 3, and the mixture 3 was mixed with the composite bacteria (the composite bacteria consisted of Angel Yeast and Bifidobacterium lactis (purchased from Hubei Haijia Biotechnology Co., Ltd.), the weight ratio of Angel Yeast to Bifidobacterium lactis was 1:2, and the viable count of the composite bacteria was 2×10 8 CFU / g or more), and sealed and fermented at 25°C for 7 days to obtain a fermentation product; the fermentation product was crushed and passed through a 100-mesh sieve, and the sieved material was collected and mixed with the alcohol extract and the filtrate 2 to obtain the traditional Chinese medicine composition.

[0053] Example 3

[0054] A traditional Chinese medicine composition for treating atherosclerotic plaques is prepared from the following raw materials: 20g of sour jujube seeds, 14g of atractylodes macrocephala, 20g of longan pulp, 12g of safflower, 18g of apricot kernel, 10g of cordyceps militaris, 6g of cistanche deserticola, 16g of astragalus, 15g of polygonatum, 10g of ginseng, 8g of peach kernel, 10g of wolfberry, 16g of tangerine peel, 18g of platycodon, 30g of angelica, 15g of ophiopogon japonicus, 22g of malt, and 16g of jujube.

[0055] The preparation method is:

[0056] Crush Semen Ziziphi Spinosae, Atractylodes Macrocephalae, Longan Meat and Safflower through a 10-mesh sieve, collect the sieved materials, and mix them to obtain a mixture 1; add 5 mL of a 70% by volume ethanol solution per 1 g of the mixture 1, mix the mixture 1 with the 70% by volume ethanol solution, reflux extract for 70 minutes, filter, and obtain a filtrate 1 and a filter residue 1; remove the ethanol solution in the filtrate 1 by rotary evaporation to obtain an alcohol extract;

[0057] Apricot kernel, Cistanche deserticola, Astragalus, Polygonatum sibiricum, Ginseng, and Platycodon grandiflorum were crushed and passed through a 10-mesh sieve, the sieved materials were collected and mixed to obtain a mixture 2, 6 mL of water was added per 1 g of the mixture 2, the mixture 2 was mixed with water and soaked for 50 min, and after the soaking, the mixture was decocted on low heat for 1.5 h, and filtered to obtain a filtrate 2 and a residue 2;

[0058] Peach kernel, orange peel and angelica are mixed and steamed for 40 minutes over high heat to obtain a steamed product, and 0.5 mL of 40-degree liquor Kouzijiao is used per 1 g of the steamed product, and the steamed product is mixed with 40-degree liquor Kouzijiao and stir-fried for 18 minutes over high heat to obtain a stir-fried product;

[0059] Cordyceps militaris, wolfberry, ophiopogon japonicus, malt, jujube, filter residue 1, filter residue 2 and stir-fried material were mixed, crushed through a 100-mesh sieve, and the sieved material was collected to obtain a mixture 3; 0.5 g of the composite bacteria was added per 100 g of the mixture 3, and the mixture 3 was mixed with the composite bacteria (the composite bacteria consisted of Angel Yeast and Bifidobacterium lactis (purchased from Hubei Haijia Biotechnology Co., Ltd.), the weight ratio of Angel Yeast to Bifidobacterium lactis was 1:3, and the viable count of the composite bacteria was 2×10 8 CFU / g or more), and sealed and fermented at 30°C for 6 days to obtain a fermentation product; the fermentation product was crushed and passed through a 100-mesh sieve, the sieved material was collected, and mixed with the alcohol extract and the filtrate 2 to obtain the traditional Chinese medicine composition.

[0060] Example 4

[0061] A Chinese medicine composition for treating atherosclerotic plaques is prepared from the following raw materials: 13g of Ziziphus jujuba seeds, 11g of Atractylodes macrocephala, 17g of Longan pulp, 8g of Safflower, 12g of Apricot kernel, 9g of Cordyceps militaris, 5g of Cistanche deserticola, 14g of Astragalus, 11g of Polygonatum, 9g of Ginseng, 4g of Peach kernel, 6g of Lycium barbarum, 15g of Tangerine peel, 16g of Platycodon grandiflorum, 24g of Angelica sinensis, 11g of Ophiopogon japonicus, 18g of Malt, and 15g of Jujube. The preparation method is the same as that of Example 1.

[0062] Comparative Example 1

[0063] The difference from Example 1 is that Angelica sinensis is not contained, and the rest is the same as Example 1.

[0064] Comparative Example 2

[0065] The difference from Example 1 is that the ratio of each raw material is: 22g of Ziziphus jujuba seed, 16g of Atractylodes macrocephala, 23g of longan pulp, 4g of safflower, 20g of almond, 12g of Cordyceps militaris, 8g of Cistanche deserticola, 18g of Astragalus, 17g of Polygonatum, 3g of ginseng, 1g of peach kernel, 15g of wolfberry, 8g of tangerine peel, 10g of Platycodon grandiflorum, 14g of Angelica sinensis, 8g of Ophiopogon japonicus, 24g of malt, and 20g of jujube, and the rest are the same as Example 1.

[0066] Comparative Example 3

[0067] The difference from Example 1 is that longan pulp, almond and platycodon are not contained, and the rest is the same as Example 1.

[0068] Comparative Example 4

[0069] The difference from Example 1 is that Radix Rehmanniae Preparata with similar efficacy is used instead of Radix Angelicae Sinensis, and Codonopsis Pilosula with similar efficacy is used instead of Radix Astragali. The rest is the same as Example 1.

[0070] Comparative Example 5

[0071] The difference from Example 1 is that the step of fermenting with composite bacteria is not included, and the rest is the same as Example 1.

[0072] Comparative Example 6

[0073] The difference from Example 1 is that 4 mL of water is added per 1 g of mixture 1, the mixture 1 is mixed with water, boiled over high heat for 50 min, filtered, and filtrate 1 and residue 1 are obtained; the rest is the same as Example 1 (the alcohol extract involved in the remaining steps of Example 1 is replaced by filtrate 1).

[0074] Comparative Example 7

[0075] The difference from Example 1 is that the steaming step is not included, and the rest is the same as Example 1.

[0076] Comparative Example 8

[0077] The difference from Example 1 is that only Angel Yeast is used for fermentation, and the rest is the same as Example 1.

[0078] Example 5

[0079] 280 C57BL / 6 mice were randomly divided into a blank control group, an atherosclerosis model group, Example 1 to Example 3 groups, Comparative Example 1 to Comparative Example 8 groups and a positive drug group (atorvastatin calcium tablet group), with 20 C57BL / 6 mice in each group. After one week of adaptive feeding, except for the blank control group which was fed with ordinary feed, the other groups were fed with high-fat feed (the high-fat feed consisted of 3% cholesterol, 10% lard, 0.2% propylthiouracil, 0.5% sodium cholate, 5% white sugar, and 81.3% ordinary feed). After 12 weeks, the positive drug group was gavaged with atorvastatin calcium tablets at a dose of 2.1 mg / kg, the Example 1 group, the Example 2 group, and the Example 3 group were gavaged with the Chinese medicine composition obtained in Example 1, Example 2, and Example 3 at a dose of 100 g / kg, the Comparative Example 1-Comparative Example 8 groups were gavaged with the Chinese medicine composition obtained in Comparative Example 1-Comparative Example 8 at a dose of 100 g / kg, and the atherosclerosis model group was gavaged with normal saline at a dose of 100 g / kg. The above-mentioned administration or normal saline was administered once a day in the morning for 4 consecutive weeks.

[0080] It was found that compared with the blank control group, the intimal thickening of the arteries in the atherosclerosis model group mice was significant, and there were a large number of foam cells and cholesterol crystals. Obvious atherosclerotic plaques were found in the aorta, indicating that the atherosclerosis model was successfully constructed. Compared with the atherosclerosis model group, the Example 1-Example 3 groups significantly reduced the degree of intimal thickening of the mice arteries, foam cells and cholesterol crystals were significantly reduced, and the atherosclerotic plaques in the aorta were significantly reduced; although the thickness of the intimal arteries in the comparative example 1-Comparative example 8 groups was reduced compared with the atherosclerosis model group, the foam cells and cholesterol crystals were reduced, and the atherosclerotic plaques were reduced, but the reduction and reduction of the above items were far less than the Example 1-Example 3 groups; the reduction and reduction of the intimal artery thickness, foam cells, cholesterol crystals and atherosclerotic plaques in the positive drug group were lower than those in the Example 1-Example 3 groups, but higher than the Comparative Example 1-Comparative Example 8 groups.

[0081] After 4 weeks of continuous administration, the mice were fasted overnight and blood was collected from the abdominal aorta after anesthesia. The blood was centrifuged after 30 minutes of storage, and serum was collected for the detection of total cholesterol (TC) and triglyceride (TG) content (the detection kits were TC kit and TG enzyme-linked immunosorbent assay kit). The average value of each group was taken. The results are shown in Table 1.

[0082] Table 1 Results of serum TC and TG levels in different groups

[0083] Group TC(pg / mL) TG (pg / mL) Blank control group 1.41 0.62 Atherosclerosis model group 4.65 1.84 Example 1 Group 1.67 0.86 Example 2 Group 1.84 0.92 Example 3 Group 1.75 0.89 Comparative Example 1 3.82 1.66 Comparative Example 2 4.06 1.71 Comparative Example 3 3.24 1.42 Comparative Example 4 2.89 1.22 Comparative Example 5 2.62 1.17 Comparative Example 6 2.46 1.03 Comparative Example 7 2.57 1.11 Comparative Example 8 2.14 1.05 Positive drug group 3.06 1.32

[0084] As can be seen from Table 1, compared with the blank control group, the TC and TG levels of the atherosclerosis model group were significantly increased (P<0.05), compared with the atherosclerosis model group, the TC and TG levels of Example 1 group, Example 2 group and Example 3 group were significantly reduced (P<0.05), and compared with the positive drug group, the TC and TG levels of Example 1 group, Example 2 group and Example 3 group were significantly reduced (P<0.05), indicating that the Chinese medicine composition of the present invention can effectively combat the formation of atherosclerotic plaques.

[0085] Example 6

[0086] 200 patients diagnosed with carotid artery plaque formation by Class A hospitals and with informed consent were collected for group treatment. The 200 patients were randomly divided into 100 TCM combination groups and 100 control groups. Among the 100 TCM combination groups, 55 were male and 45 were female, with an average age of 55 years old. There was 1 plaque in the carotid artery and the plaque was between 10% and 40%; among the 100 control groups, 57 were male and 43 were female, with an average age of 56 years old. There was 1 plaque in the carotid artery and the plaque was between 10% and 40%. There was no significant difference in the condition, gender, age, and course of disease between the TCM combination group and the control group after statistical processing, and they were comparable.

[0087] Control group: taking atorvastatin calcium tablets and aspirin (Bayer Aspirin), atorvastatin calcium tablets 10 mg each time, once a day, aspirin (Bayer Aspirin) 100 mg each time, once a day, 30 days as a course of treatment, 4 courses of treatment.

[0088] Chinese medicine composition group: take the Chinese medicine composition obtained in Example 1 twice a day, morning and evening (the Chinese medicine composition obtained in Example 1 is a daily dose). 30 days is a course of treatment, and the medicine is taken for 3 courses.

[0089] Efficacy evaluation criteria:

[0090] According to the standards of "Guidelines for Clinical Research of New Chinese Medicines" and "Standards for Diagnosis and Efficacy of TCM Diseases and Syndromes", and by color Doppler ultrasound examination of the carotid artery:

[0091] Cured: the plaque disappears; markedly effective: the plaque size decreases by more than 8%; effective: the plaque thickness and area remain unchanged, or the plaque size decreases by less than 8%; ineffective: the plaque thickness and area increase by more than 0.2 mm.

[0092] The results are shown in Table 2, where the total effective rate = [(cured + markedly effective + effective) / total number of cases] × 100%. As can be seen from Table 2, the Chinese medicine composition of the present invention can effectively ablate atherosclerotic plaques and has a significant therapeutic effect on atherosclerotic diseases.

[0093] Table 2 Statistical results of treatment of two groups of patients

[0094] Group Total number of cases cure Significant effect efficient invalid Total Effectiveness Chinese medicine combination group 100 60 26 13 1 99% Control group 100 55 20 23 2 98%

[0095] Example 7

[0096] One hundred C57BL / 6 mice were randomly divided into a blank control group and an atherosclerosis model group, with 50 mice in each group. After one week of adaptive feeding, the atherosclerosis model group was fed with a high-fat diet (the high-fat diet consisted of 3% cholesterol, 10% lard, 0.2% propylthiouracil, 0.5% sodium cholate, 5% white sugar, and 81.3% ordinary diet) except for the blank control group which was fed with ordinary diet. After 16 weeks, color Doppler ultrasound showed obvious atherosclerotic plaques in the aorta of the atherosclerosis model group, indicating that the atherosclerosis model was successfully constructed.

[0097] The blank control group and the atherosclerosis model group were gavaged with the Chinese medicine composition obtained in Example 1 according to the dosage of 400g / kg, and the medicine was administered twice a day for 4 consecutive weeks. After 4 weeks of administration, blood was drawn to detect blood sugar, blood lipids, hemoglobin, liver function index and renal function index. The results showed that the blood sugar, blood lipids, hemoglobin, liver function index and renal function index of the blank control group all met normal values, and the blood sugar, blood lipids, hemoglobin, liver function index and renal function index of the atherosclerosis model group all had benign improvement, and tended to normal values. After the end of blood drawing, 20 C57BL / 6 mice were randomly selected from two groups and killed, and heart, liver, kidney, spleen and stomach were taken, and tissue sections were observed, and the results showed that the Chinese medicine composition of the present invention had no adverse effects on each organ of two groups of C57BL / 6 mice.

[0098] Example 8

[0099] According to the "Guidelines for the Classification, Diagnosis and Treatment of Pulmonary Nodules in China (2020 Edition)", referring to the "Guidelines for Clinical Research of New Chinese Medicines (2002 Edition)", and based on the lung CT scan reports of patients in Class-A tertiary hospitals, the size and regular shape of lung nodules were determined, and then 100 patients with solid lung nodules were selected (patients with allergic constitution, cardiovascular, liver and kidney diseases, and breastfeeding and pregnant women were excluded). Among them, 20 patients had solid nodules less than 0.4 cm, and 80 patients had solid nodules larger than 0.4 cm. The average age of the 100 patients was 45 years old.

[0100] The method of taking is: the above 100 patients are evenly divided into 2 groups, the experimental group and the control group, the experimental group has 50 cases, among which 10 patients with solid nodules below 0.4cm and 40 patients with solid nodules greater than 0.4cm; the control group has 50 cases, among which 10 patients with solid nodules below 0.4cm and 40 patients with solid nodules greater than 0.4cm. The experimental group takes the Chinese medicine composition obtained in Example 1, twice a day (the Chinese medicine composition obtained in Example 1 is the amount for one day), and takes the medicine for 40 days in total. The control group takes Qingfei Sanjie Pills, 3g once, twice a day, for a total of 40 days. During the period when the above-mentioned patients take the Chinese medicine composition of Example 1 of the present invention and drink the control group medicine, it is strictly forbidden to take other similar drugs, avoid eating spicy and dry food, prohibit smoking and drinking, and stop taking them immediately if there are adverse reactions during taking.

[0101] Efficacy evaluation criteria: After the end of medication, the hospital will review the CT scan 20 days later. Cured, the lung nodules diagnosed by CT scan disappeared; markedly effective, the lung nodules diagnosed by CT scan shrank; effective, the lung nodules diagnosed by CT scan did not increase or increase; ineffective, the lung nodules diagnosed by CT scan increased or increased.

[0102] The results are shown in Table 3, where the total effective rate = [(cured + markedly effective + effective) / total number of cases] × 100%. As can be seen from Table 3, the Chinese medicine composition of the present invention can effectively ablate lung nodules.

[0103] Table 3 Statistical results of treatment of two groups of patients

[0104] Group Total number of cases cure Significant effect efficient invalid Total Effectiveness Chinese medicine combination group 50 18 30 1 1 98% Control group 50 10 28 10 2 96%

[0105] The patients in the above-mentioned experimental group underwent electrocardiogram, blood, urine and stool tests, and heart, liver and kidney function tests in a 3A hospital before and after taking the Chinese medicine composition of Example 1 of the present invention. The results showed that before and after taking the Chinese medicine composition of Example 1 of the present invention, the above-mentioned 50 patients did not experience adverse reactions and had no toxic side effects.

[0106] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine composition for promoting ablation of atherosclerotic plaques and pulmonary nodules, characterized in that: The Chinese medicine composition comprises the following raw materials in parts by weight: 10-20 parts of spinach seed, 7-14 parts of atractylodes macrocephala, 15-20 parts of longan pulp, 6-12 parts of safflower, 9-18 parts of apricot kernel, 5-10 parts of cordyceps militaris, 3-6 parts of cistanche deserticola, 9-16 parts of astragalus, 10-15 parts of polygonatum, 6-10 parts of ginseng, 2-8 parts of peach kernel, 4-10 parts of wolfberry, 12-16 parts of tangerine peel, 13-18 parts of platycodon, 20-30 parts of angelica, 10-15 parts of ophiopogon japonicus, 16-22 parts of malt and 8-16 parts of jujube.

2. The method for preparing the Chinese medicine composition according to claim 1, characterized in that: The steps include: Mixing spiny jujube seeds, white atractylodes, longan pulp and safflower to obtain a mixture 1, mixing the mixture 1 with an ethanol solution with a volume fraction of 70%-90%, refluxing extraction, filtering to obtain a filtrate 1 and a filter residue 1, and removing the ethanol solution in the filtrate 1 to obtain an alcohol extract; Apricot kernel, Cistanche deserticola, Astragalus, Polygonatum sibiricum, Ginseng, and Platycodon grandiflorum are mixed to obtain a mixture 2, and the mixture 2 is mixed with water, soaked, boiled, and filtered to obtain a filtrate 2 and a filter residue 2; Steaming peach kernel, orange peel and angelica sinensis to obtain a steamed product, mixing the steamed product with 40-degree liquor and frying for 10-20 minutes to obtain a stir-fried product; Cordyceps militaris, wolfberry, ophiopogon japonicus, malt, jujube, filter residue 1, filter residue 2 and stir-fried product are mixed to obtain mixture 3; mixture 3 is mixed with composite bacteria, and sealed and fermented for 4-7 days at 25-30°C to obtain fermentation product; the fermentation product, alcohol extract and filtrate 2 are mixed to obtain the Chinese medicine composition; the composite bacteria are composed of Angel yeast and Bifidobacterium lactis, and the number of viable bacteria of the composite bacteria is 2×10 8 CFU / g and above.

3. The preparation method according to claim 2, characterized in that: The mass volume ratio of the mixture 1 to the ethanol solution with a volume fraction of 70%-90% is 1g:3-5mL.

4. The preparation method according to claim 2, characterized in that: The mass volume ratio of the mixture 2 to water is 1 g:4-6 mL.

5. The preparation method according to claim 2, characterized in that: The soaking time is 30-50 minutes.

6. The preparation method according to claim 2, characterized in that: The decocting time is 0.5-1.5h.

7. The preparation method according to claim 2, characterized in that: The mass volume ratio of the steamed product to 40-proof liquor is 1 g: 0.2-0.5 mL.

8. The preparation method according to claim 2, characterized in that: The amount of the composite bacteria is calculated based on the weight of the mixture 3, and 0.2-0.5 g of the composite bacteria is added per 100 g of the mixture 3.

9. The preparation method according to claim 2, characterized in that: The weight ratio of Angel Yeast to Bifidobacterium lactis in the composite bacteria is 1:2-3.

10. Use of the Chinese medicine composition according to claim 1 or the preparation method according to any one of claims 2 to 9 in the preparation of atherosclerotic plaque ablation and / or pulmonary nodule ablation products.